Effects of Age, Body Mass Index (BMI), Gender, and Race Sitagliptin Based on a population pharmacokinetic analysis or a composite analysis of available pharmacokinetic data, BMI, gender, and race do not have a clinically meaningful effect on the pharmacokinetics of sitagliptin
I recently gave a talk at TEDMED that explains this new way of treating the underlying causes of disease based on the emerging science of systems medicine
Frontiers in Endocrinology, 15, Article PMC10714284
Existing inventories for sale, they've picked up from historic lows in 2023, but they're still very, very low on a long-run basis
Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression
untreated diabetic animals (D) received 1 mL of the formulation containing the vehicle (n = 11)